Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

You search for a phrase ""Nishimura, T."" according to the criterion: Author


Title:
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
Authors:
Handabile C; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Ohno M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.
Sekiya T; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Nomura N; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of International Research Promotion, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kawakita T; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kawahara M; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Endo M; KM Biologics Co. Ltd, Kumamoto, Japan.
Nishimura T; KM Biologics Co. Ltd, Kumamoto, Japan.
Okumura M; KM Biologics Co. Ltd, Kumamoto, Japan.
Toba S; Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, Toyonaka, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sasaki M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Orba Y; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Chua BY; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Rowntree LC; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Nguyen THO; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Shingai M; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sato A; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; Shionogi Pharmaceutical Research Center, Shionogi & Company, Limited, Toyonaka, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sawa H; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; One Health Research Center, Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Ogasawara K; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Kedzierska K; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.; Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Kida H; Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan. .; Division of Biologics Development, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .; International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .; Division of Vaccine Immunology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. .
Show more
Source:
Scientific reports [Sci Rep] 2024 Feb 20; Vol. 14 (1), pp. 4204. Date of Electronic Publication: 2024 Feb 20.
Publication Type:
Journal Article
MeSH Terms:
Influenza, Human*
Influenza Vaccines*
Influenza A Virus, H1N1 Subtype*
COVID-19*/prevention & control
Animals ; Mice ; Humans ; COVID-19 Vaccines ; Antibodies, Viral ; SARS-CoV-2 ; Vaccination/methods ; Virion ; Immunogenicity, Vaccine
Academic Journal
Title:
Development of a rating scale for maladaptive symptoms by maltreatment: Perspectives of attachment and dissociation.
Authors:
Horiuchi A; Division of Developmental Neuroscience, United Graduate School of Child Development, Osaka University, Suita, Japan.
Nishimura T; Research Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Taniike M; Division of Developmental Neuroscience, United Graduate School of Child Development, Osaka University, Suita, Japan.; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Suita, Japan.; Department of Pediatrics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Tachibana M; Division of Developmental Neuroscience, United Graduate School of Child Development, Osaka University, Suita, Japan.; Molecular Research Center for Children's Mental Development, United Graduate School of Child Development, Osaka University, Suita, Japan.; Department of Pediatrics, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Show more
Source:
PloS one [PLoS One] 2024 Feb 14; Vol. 19 (2), pp. e0298214. Date of Electronic Publication: 2024 Feb 14 (Print Publication: 2024).
Publication Type:
Journal Article
MeSH Terms:
Child Abuse*/diagnosis
Neurodevelopmental Disorders*
Child ; Humans ; Reproducibility of Results ; ROC Curve ; Dissociative Disorders
Academic Journal
Title:
Conformation of Horizontal Extraocular Muscle Insertions in Acute Acquired Concomitant Esotropia Induced by Excessive Digital Device Usage.
Authors:
Hayashi R; Department of Ophthalmology, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama, Japan.
Hayashi S; Department of Ophthalmology, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama, Japan.; Lively Eye Clinic, Soka, Saitama, Japan.
Nishimura T; Department of Ophthalmology, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama, Japan.
Machida S; Department of Ophthalmology, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama, Japan.
Show more
Source:
Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2024 Jan 06; Vol. 18, pp. 41-47. Date of Electronic Publication: 2024 Jan 06 (Print Publication: 2024).
Publication Type:
Journal Article
Academic Journal

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.